Camp4 Therapeutics (CAMP) Operating Margin (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Operating Margin came in at 1010.12% in Q1 2026, up 51668.0% year-on-year from N/an in Q1 2025, and up 72.49% quarter-over-quarter from 3671.26% in Q4 2025.
Camp4 Therapeutics (CAMP) Operating Margin (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Operating Margin across 4 years of filings, most recently posting 1010.12% for Q1 2026.
- Operating Margin for Q1 2026 came in at 1010.12%, up 51668.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1335.18% (up 219542.0% YoY), and the FY2025 annual result was 1502.43%, up 663990.0% from the prior year.
- Operating Margin came in at 1010.12% for Q1 2026 at Camp4 Therapeutics, up from 3671.26% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 870.27% in Q2 2025 to a low of 3671.26% in Q4 2025.
- The 4-year median for Operating Margin is 1717.11% (2025), against an average of 2067.6%.
- Across the five-year window, Operating Margin tumbled 151881 bps in 2025 and surged 51668 bps in 2026, its largest moves.
- Camp4 Therapeutics' Operating Margin stood at 3525.14% in 2023, then jumped by 39 bps to 2152.45% in 2024, then tumbled by 71 bps to 3671.26% in 2025, then surged by 72 bps to 1010.12% in 2026.
- The last three Operating Margin figures came in at 1010.12% (Q1 2026), 3671.26% (Q4 2025), and 1717.11% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | -1,010.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,010.12% |
| Dec 31, 2025 | -3,671.26% |
| Sep 30, 2025 | -1,717.11% |
| Jun 30, 2025 | -870.27% |
| Mar 31, 2025 | -1,526.81% |
| Dec 31, 2024 | -2,152.45% |
| Sep 30, 2023 | -3,525.14% |